In keeping with its approach to regulating medical products and foods, FDA is applying a risk-based view in determining how it would cut more than $300 million from its budget if sequestration passes.
“We will be looking at how to manage potential budget cuts in an across-the-board way, really trying to do it with a risk-based approach … in a way that will minimize negative impacts on people, health and safety,” FDA
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?